Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
PaperCitations, authors & open-access status
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 155 citations, 2020 year and green oa status.
155
Citations
2020
Year
green
OA Status